title: Antinociceptive effects of synthetic chalcones obtained from xanthoxyline.
abstract: A wide variety of noxious stimuli are known to induce a sensation of pain evoked in a remote region of the body. Here, we show that chalcones can inhibit the pain provoked by the administration of an intraperitoneal acetic acid (AA). This study investigates the effects of 17 synthetic chalcones in the writhing test, a visceral pain model in mice. The majority of these compounds proved more active than some analgesic drugs, such as aspirin and acetaminophen, two reference drugs used here for comparison. Four chalcones, 9, 10, 16, and 17, were selected for more detailed studies, since they exhibited significant antinociceptive activities and chemical structures of interest. They caused dose-related inhibitions, proving about 15-, 10-, 9-, and 8-fold more active than the standard drugs. When administrated orally, only chalcone 9 proved to be effective. These chalcones might be further used as a model to obtain new and more potent analgesic drugs.
authors.affiliation: Programa de Mestrado em Ciências Farmacêuticas e Núcleo de Investigações Químico-Farmacêuticas (NIQFAR)/CCS, Universidade do Vale do Itajaí (UNIVALI), Itajaí-SC, Brazil.
authors.forename: Fátima
authors.initials: F
authors.lastname: de Campos-Buzzi
authors.forename: Jordana
authors.initials: J
authors.lastname: Pereira de Campos
authors.forename: Patrícia
authors.initials: P
authors.lastname: Pozza Tonini
authors.forename: Rogério
authors.initials: R
authors.lastname: Corrêa
authors.forename: Rosendo
authors.initials: R
authors.lastname: Augusto Yunes
authors.forename: Paula
authors.initials: P
authors.lastname: Boeck
authors.forename: Valdir
authors.initials: V
authors.lastname: Cechinel-Filho
mesh_terms: D000082:Acetaminophen / Q000008:administration & dosage / Q000494:pharmacology; D019342:Acetic Acid / Q000008:administration & dosage / Q000633:toxicity; D000098:Acetophenones / Q000737:chemistry*; D000284:Administration, Oral; D000700:Analgesics / Q000008:administration & dosage / Q000138:chemical synthesis / Q000494:pharmacology*; D000818:Animals; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology; D047188:Chalcones / Q000008:administration & dosage / Q000138:chemical synthesis / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical / Q000379:methods; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D015394:Molecular Structure; D010146:Pain / Q000139:chemically induced / Q000188:drug therapy*; D010147:Pain Measurement / Q000379:methods; D013329:Structure-Activity Relationship
chemical_list: C514570:2',4'-dimethoxy-6'-hydroxychalcone; D000098:Acetophenones; D000700:Analgesics; D047188:Chalcones; D000082:Acetaminophen; D019342:Acetic Acid; D001241:Aspirin; C064382:xanthoxyline